supported by the project EFSA-CDN(Project No.:CZ.02.01/0.0/0.0/16_019/0000841)co-funded by ERDF.
Levothyroxine is a drug with a narrow therapeutic index.Changing the drug formulation composition or switching between pharmaceutical brands can alter the bioavailability,which can result in major health problems.Howe...
BACKGROUND With an ongoing demand for transplantable organs,optimization of donor management protocols,specifically in trauma populations,is important for obta-ining a high yield of viable organs per patient.Endocrine...
Introduction: Thyroid states can be associated with psychiatric manifestations, be it hypothyroid, hyperthyroid or even euthyroid. The effect of depression is significant in subclinical hypothyroidism. Sometimes, its ...
Resistance to Thyroid Hormone (RTH) is a rare form of hormone resistance secondary to changes in the genes encoding thyroid hormone receptors. The two subtypes, Pituitary RTH (PRTH) and Generalized RTH (GRTH), cause c...
BACKGROUND The literature on thyrotoxicosis caused by excessive ingestion of exogenous thyroid hormone is limited,and most cases reported have involved pediatric clinical studies.CASE SUMMARY A 21-year-old woman initi...
To analyze the clinical effect of low-dose levothyroxine in the treatment of benign thyroid nodules. Methods: 98 patients with benign thyroid nodules in our hospital were randomly divided into control group and observ...
Objective: to study the effect of levothyroxine tablets in the clinical treatment of pregnant patients with hypothyroidism and the impact of pregnancy outcome. Methods: this study selected 78 cases of pregnancy with h...
Goiter is an enlargement of the thyroid gland which can be associated with a number of complications both for the mother and the fetus. A 34-year-old pregnant woman with normal thyroid function was referred to our Dep...
Rationale: Levothyroxine is the most commonly used agent in thyroid hormone replacement therapy. Although there are many hypothyroid patients who use levothyroxine as a treatment, high level of thyroid stimulating hor...
To the Editor: On March 9, 2018, a 31-year-old woman presented with liver dysfunction after thyroid cancer surgery. She was physically healthy;had no chronic diseases, such as hypertension and diabetes;had no history ...